Observation of SASE in LEBRA FEL systemT Tanaka; K Hayakawa; I Sato; Y Hayakawa; K Yokoyama · 2004

Stability of the LEBRA infrared FELK Yokoyama; I Sato; K Hayakawa; T Tanaka; Y Hayakawa; K Kanno; T Sakai; K Ishiwata; E Hashimoto · 2003

Status of Infrared Free Electron Laser at Nihon UniversityTanaka, T.; Sato, I.; Hayakawa, K.; Hayakawa, Y.; Sato, K. · Japanese Journal of Applied Physics · 2002

Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway InflammationHayakawa, H.; Hayakawa, M.; Kume, A.; Tominaga, S.-i. · Journal of Biological Chemistry · 2007

) ReactionsHayakawa, S. I.; Fujiwara, M.; Imanishi, S.; Fujita, Y.; Katayama, I.; Morinobu, S.; Yamazaki, T.; Itahashi, T.; Ikegami, H. · Physical Review Letters · 1982

, <i>48</i> , <i>50</i> TiHigashi, A.; Katori, K.; Fujiwara, M.; Ikegami, H.; Katayama, I.; Morinobu, S.; Tosaki, M.; Hayakawa, S. I.; Ikeda, N.; Miyatake, H. · Physical Review C · 1989

Decay ofHayakawa, H. I.; Hyman, I.; Lee, J. K. P. · Physical Review C · 1980

Synthesis of (-)-Pestalotiopsin ATakao, K.-i.; Hayakawa, N.; Yamada, R.; Yamaguchi, T.; Morita, U.; Kawasaki, S.; Tadano, K.-i. · Synfacts · 2008

Cyclophilin inhibitors as antiviral agentsPeel, Michael; Scribner, Andrew · Bioorganic & Medicinal Chemistry Letters · 2013

HIV/AIDS eradicationMarsden, Matthew D.; Zack, Jerome A. · Bioorganic & Medicinal Chemistry Letters · 2013

Selective orexin receptor antagonistsLebold, Terry P.; Bonaventure, Pascal; Shireman, Brock T. · Bioorganic & Medicinal Chemistry Letters · 2013

Graphical contents listBioorganic & Medicinal Chemistry Letters · 2013

REDOR NMR for drug discoveryCegelski, Lynette · Bioorganic & Medicinal Chemistry Letters · 2013

Editorial boardBioorganic & Medicinal Chemistry Letters · 2014

Graphical contents listBioorganic & Medicinal Chemistry Letters · 2014

Editorial boardBioorganic & Medicinal Chemistry Letters · 2013